Clinical trial
A Longitudinal, Multi-Center Safety Study of Autologous Adult Adipose-Derived Regenerative Cell Injection Into Chronic Partial-Thickness Rotator Cuff Tears
NCT05400798 is registered in ClinicalTrials.gov with InGeneron, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Longitudinal, Multi-Center Safety Study of Autologous Adult Adipose-Derived Regenerative Cell Injection Into Chronic Partial-Thickness Rotator Cuff Tears
- Lead sponsor
- InGeneron, Inc.
- Phase
- Not applicable
- Overall status
- Enrolling by invitation
- Start date
- January 1, 2022
- Completion date
- December 30, 2025
- Enrollment
- 246 (estimated)
- Sites
- 11
Conditions
As the registry lists them; a condition with its own page is linked.
partial thickness rotator cuff tear